FFCP PHASE1:Mm9::chr13:27734440..27734445,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=19113|HGNC=|MCL_coexpression_id=56|UniProt=Q8BMT3,O54830|association_with_transcript=-78bp_to_ENSMUST00000171705,NM_001164058,NM_008930,uc007pxy.2,uc007pxz.2_5end|description=CAGE_peak_3_at_Prl7a1_5end|id=chr13:27734440..27734445,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0005631!1.18e-44!3;UBERON:0000478!1.18e-44!3;UBERON:0000158!1.18e-44!3;UBERON:0005795!1.58e-33!4;UBERON:0000995!1.58e-33!4;UBERON:0001987!1.73e-30!2;UBERON:0003124!1.73e-30!2;UBERON:0004340!1.73e-30!2;UBERON:0003975!5.12e-27!5;UBERON:0003134!3.19e-17!8;UBERON:0000305!6.79e-16!1;UBERON:0006834!1.33e-15!1;UBERON:0004175!2.11e-15!9;UBERON:0000474!2.11e-15!9;UBERON:0003100!9.53e-13!11|ontology_enrichment_uberon_v019_2=UBERON:0001987,4.52e-44,2;UBERON:0003124,4.52e-44,2;UBERON:0004340,4.52e-44,2;UBERON:0005631,5.61e-30,3;UBERON:0000478,5.61e-30,3;UBERON:0000158,5.61e-30,3;UBERON:0005795,6.52e-23,4;UBERON:0000995,6.52e-23,4;UBERON:0003975,1.16e-18,5;UBERON:0003134,2.93e-12,8;UBERON:0004175,4.56e-11,9;UBERON:0000474,4.56e-11,9;UBERON:0003100,2.51e-09,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.247194967734374,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.238968797952552,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.50949465803873,0.63549621259146,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.179427713218951,0,0,0.187682475451182,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p3@Prl7a1}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=entrezgene:19113 | |||
|HGNC= | |||
|MCL_coexpression_id=56 | |||
|TSSclassifier=NA | |||
|UniProt=uniprot:Q8BMT3,uniprot:O54830 | |||
|association_with_transcript=-78bp_to_ENSMUST00000171705,NM_001164058,NM_008930,uc007pxy.2,uc007pxz.2_5end | |||
|cluster_id=chr13:27734440..27734445,- | |||
|description=CAGE_peak_3_at_Prl7a1_5end | |||
|id=chr13:27734440..27734445,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0005631!1.18e-44!3;UBERON:0000478!1.18e-44!3;UBERON:0000158!1.18e-44!3;UBERON:0005795!1.58e-33!4;UBERON:0000995!1.58e-33!4;UBERON:0001987!1.73e-30!2;UBERON:0003124!1.73e-30!2;UBERON:0004340!1.73e-30!2;UBERON:0003975!5.12e-27!5;UBERON:0003134!3.19e-17!8;UBERON:0000305!6.79e-16!1;UBERON:0006834!1.33e-15!1;UBERON:0004175!2.11e-15!9;UBERON:0000474!2.11e-15!9;UBERON:0003100!9.53e-13!11 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001987,4.52e-44,2;UBERON:0003124,4.52e-44,2;UBERON:0004340,4.52e-44,2;UBERON:0005631,5.61e-30,3;UBERON:0000478,5.61e-30,3;UBERON:0000158,5.61e-30,3;UBERON:0005795,6.52e-23,4;UBERON:0000995,6.52e-23,4;UBERON:0003975,1.16e-18,5;UBERON:0003134,2.93e-12,8;UBERON:0004175,4.56e-11,9;UBERON:0000474,4.56e-11,9;UBERON:0003100,2.51e-09,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.247194967734374,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.238968797952552,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,7.50949465803873,0.63549621259146,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.179427713218951,0,0,0.187682475451182,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p3@Prl7a1 | |||
}} |
Revision as of 20:51, 5 August 2015
Short description: | p3@Prl7a1 |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_3_at_Prl7a1_5end |
Coexpression cluster: | MCL_coexpression_mm9:56 |
Association with transcript: | -78bp_to_ENSMUST00000171705, NM_001164058, NM_008930, uc007pxy.2, uc007pxz.2_5end |
EntrezGene: | 19113 |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
placenta | 4.52e-44 | 2 |
chorion | 4.52e-44 | 2 |
allantois | 4.52e-44 | 2 |
extraembryonic membrane | 5.61e-30 | 3 |
extraembryonic structure | 5.61e-30 | 3 |
membranous layer | 5.61e-30 | 3 |
embryonic uterus | 6.52e-23 | 4 |
uterus | 6.52e-23 | 4 |
internal female genitalia | 1.16e-18 | 5 |
female reproductive organ | 2.93e-12 | 8 |
internal genitalia | 4.56e-11 | 9 |
female reproductive system | 4.56e-11 | 9 |
female organism | 2.51e-09 | 11 |